Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate Vaccine - Concepedia

Concepedia

Publication | Closed Access

Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate Vaccine

29

Citations

27

References

2010

Year

Ameneh Khatami, Matthew D. Snape, Tessa M. John, Sharon Westcar, Chaam L. Klinger, Llinos Rollinson, Dominique Boutriau, Narcisa Mesaros, Jacek Wysocki, Ly‐Mee Yu,

The Pediatric Infectious Disease Journal

Abstract

A toddler Hib-MenC-TT booster helps sustain immunity against Hib to 3½ years of age. Persistence of MenC antibody is similar in children primed with MenC-CRM197 in infancy who receive a booster Hib-MenC-TT, to those who receive no booster. Persistence of MenC antibody is better when primed and boosted with Hib-MenC-TT.

References

	Year	Citations

Page 1